ArticleCancer immunology, immunotherapy : CII2014

Combination of an agonistic anti-CD40 monoclonal antibody and the COX-2 inhibitor celecoxib induces anti-glioma effects by promotion of type-1 immunity in myeloid cells and T-cells.

Akemi Kosaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.